Ozempic & GLP-1 drugs - Why 90% Still Fail | Prevention is Cure Ep# 45
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Ozempic & GLP-1 drugs - Why 90% Still Fail | Prevention is Cure Ep# 45
-
ナレーター：
-
著者：
In this episode of Prevention Is Cure, Prof Grant Schofield and Sam Schofield dive deep into the most explosive topic in metabolic health right now - have we actually cracked weight loss and aging? From the latest GLP-1 triple agonists showing 30% body weight loss, to gene therapies that can reverse the age of individual cells, the science is moving faster than most people realise.But here's the uncomfortable truth: 9 out of 10 people regain the weight when they stop. The "Ozempic personality" is real. And the first human trial of Yamanaka factor therapy just began.
We cover:
→ The 4 weight loss options (and which actually works long-term)
→ The newest GLP-1 drugs you've never heard of — and can't pronounce
→ What "food noise" is and why killing it might cost you more than hunger
→ Longevity escape velocity — the first person to live to 1,000 may already be born
→ Yamanaka factors and the science of reversing cellular age
→ Why Grant believes prescribing these drugs without behaviour change is unethical
🎙️ Prevention Is Cure with Prof Grant Schofield & Guest Host Sam Schofield
Subscribe for conversations on metabolic health, longevity, and the science of living well.
#weightloss #GLP1 #Ozempic #longevity #metabolichealth #preventioniscure